<ul><li>OncoMRD is a multi-spectral integrated gene panel developed by OncoDxRx for monitoring residual disease in solid tumors.</li><li>It employs patient-unique gene signatures to detect, identify, quantify, and track signals from tumors.</li><li>OncoMRD uses overactive genes and biomarkers in major cancer pathways to calculate an OncoMRD score based on gene expression levels.</li><li>The system provides MRD detection and trending functions, along with high-quality tumor activity and aggressiveness information.</li></ul>

OncoMRD: OncoDxRx’s multi-spectral integrated gene panel for monitoring residual disease in solid…

Discover more